Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer

Receptor Conversion ◽

Recurrent Breast ◽

PO85 CHARACTERISTICS AND PROGNOSIS OF HORMONE RECEPTOR POSITIVE AND HER2 NEGATIVE RECURRENT BREAST CANCER PATIENTS RECEIVING POSTOPERATIVE AROMATASE INHIBITOR

The Breast ◽

10.1016/s0960-9776(13)70098-5 ◽

2013 ◽

Vol 22 ◽

pp. S48-S49

Author(s):

Ishida Mayumi ◽

Igawa Akiko ◽

Saruwatari Akihiro ◽

Oikawa Masahiro ◽

Koga Chinami ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Hormone Receptor ◽

Recurrent Breast Cancer ◽

Breast Cancer Patients ◽

Recurrent Breast

A Case of Hormone Receptor-positive Recurrent Breast Cancer in which Stable Disease Condition was Achieved by Olaparib

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ◽

10.3919/jjsa.82.1084 ◽

2021 ◽

Vol 82 (6) ◽

pp. 1084-1088

Author(s):

Ai YAMAGUCHI ◽

Tomoe TAJI ◽

Hirofumi SUWA

Keyword(s):

Breast Cancer ◽

Stable Disease ◽

Hormone Receptor ◽

Recurrent Breast Cancer ◽

Disease Condition ◽

Recurrent Breast ◽

Positive Recurrent

Abstract P3-11-06: A phase 1 study of KHK2375 (entinostat) as monotherapy and in combination with exemestane in Japanese patients with hormone receptor-positive, HER2-negative, advanced or recurrent breast cancer

10.1158/1538-7445.sabcs17-p3-11-06 ◽

2018 ◽

Author(s):

A Shimomura ◽

N Masuda ◽

K Tamura ◽

H Yasojima ◽

M Sawaki ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Phase 1 ◽

Japanese Patients ◽

Recurrent Breast Cancer ◽

Phase 1 Study ◽

Recurrent Breast

P172 Prognosis of hormone receptor positive recurrent breast cancer during endocrine therapy

The Breast ◽

10.1016/s0960-9776(15)70213-4 ◽

2015 ◽

Vol 24 ◽

pp. S84

Author(s):

S. Akiyoshi ◽

M. Oikawa ◽

Y. Koi ◽

C. Koga ◽

S. Nishimura ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Recurrent Breast Cancer ◽

Recurrent Breast ◽

Positive Recurrent

Impact of Visceral Metastasis on Efficacy of Fulvestrant in Patients with Hormone Receptor-positive Recurrent Breast Cancer

Anticancer Research ◽

10.21873/anticanres.12387 ◽

2018 ◽

Vol 38 (3) ◽

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Recurrent Breast Cancer ◽

Visceral Metastasis ◽

Recurrent Breast ◽

Positive Recurrent

Diagnostic delay is more frequent in triple negative breast cancer than in hormone receptor-positive breast cancer

10.1055/s-0040-1710602 ◽

2020 ◽

Author(s):

S Baumgartner ◽

U Güth ◽

K Reeve ◽

C Elfgen

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Hormone Receptor ◽

Triple Negative ◽

Diagnostic Delay ◽

Faculty Opinions recommendation of Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734467013.793556634 ◽

2019 ◽

Author(s):

Eva Chalas

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Endocrine Therapy ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Hormone Receptor ◽

Adjuvant Endocrine Therapy ◽

HOXB7 siRNA delivered by hybrid nanoparticles and the co-therapy with tamoxifen: promising strategy against hormone receptor positive breast cancer

10.3390/iocn2020-07845 ◽

2020 ◽

Author(s):

Frederico Pittella ◽

Ana Beatriz Valle ◽

Ana Cristina Gualberto ◽

Kézia Ferreira ◽

Tânia Pasa ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Hybrid Nanoparticles ◽

Promising Strategy ◽

7P An optimized Breast Cancer Index node-positive (BCIN+) prognostic model for late distant recurrence in patients with hormone receptor-positive (HR+) node-positive breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.03.021 ◽

2021 ◽

Vol 32 ◽

pp. S23-S24

Author(s):

G-J. Liefers ◽

I. Noordhoek ◽

Y. Zhang ◽

D.C. Sgroi ◽

H. Putter ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Prognostic Model ◽

Distant Recurrence ◽

Node Positive ◽

Breast Cancer Index ◽

Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study

The Breast ◽

10.1016/j.breast.2021.06.003 ◽

2021 ◽

Author(s):

Ariane Mamguem Kamga ◽

Oumar Billa ◽

Sylvain Ladoire ◽

Marie-Laure Poillot ◽

Geneviève Jolimoy ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Population Based ◽

Population Based Study ◽